Recurrent Oligodendroglioma
2 clinical trials · Condition
◉ Watch Recurrent Oligodendroglioma
| Record | Firm | Date |
|---|---|---|
| PARP Inhibition for Gliomas (PI-4G or π4g) (NCT05297864) | University of Oklahoma | 2022-06-09 |
Track Recurrent Oligodendroglioma automatically
Every clearance here is in the API, with alerts when new ones post.